85 related articles for article (PubMed ID: 6199442)
1. [Immunohistological study on the histogenesis and malignant transformation of ovarian mucinous tumors, with special reference to the intestinal metaplasia].
Tanaka Y; Ueda G; Inoue M; Hiramatsu K; Inoue Y; Saito J; Nishino T; Yamasaki M; Kurachi K; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):67-71. PubMed ID: 6199442
[TBL] [Abstract][Full Text] [Related]
2. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
3. [Histogenetic considerations on mucinous cystomas of the ovary based on histochemical and immunohistochemical findings].
Lapertosa G
Pathologica; 1989; 81(1074):381-401. PubMed ID: 2696922
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
Zhong CQ
Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
[TBL] [Abstract][Full Text] [Related]
5. [Epithelial metaplasia in gastric or intestinal type and malignant transformation in mucinous ovarian tumors].
Chen G; Wang ZM
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):174-6. PubMed ID: 1335847
[TBL] [Abstract][Full Text] [Related]
6. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
Gaggero G; Sola S; Mora M; Fulcheri E
Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological study of mucous antigens in gynecologic tumors with special reference to argyrophil cells.
Ueda G; Tanaka Y; Hiramatsu K; Inoue Y; Yamasaki M; Inoue M; Kurachi K; Mori T
Int J Gynecol Pathol; 1982; 1(1):41-5. PubMed ID: 7184890
[TBL] [Abstract][Full Text] [Related]
8. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistological demonstration of peptide hormones and serotonin in ovarian mucinous and endometrioid tumors with argyrophil cells].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Nishino T; Saito J; Abe Y; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):361-5. PubMed ID: 2871119
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of HNK-1-defined antigen in gynecologic tumors with argyrophilia.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Abe Y; Tanizawa O
Int J Gynecol Pathol; 1986; 5(2):143-50. PubMed ID: 2424852
[TBL] [Abstract][Full Text] [Related]
11. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
12. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
13. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
[TBL] [Abstract][Full Text] [Related]
14. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
15. Histogenesis of Brenner tumors, II: histochemistry and CEA.
Shevchuk MM; Fenoglio CM; Richart RM
Cancer; 1980 Dec; 46(12):2617-22. PubMed ID: 7004621
[TBL] [Abstract][Full Text] [Related]
16. Mucinous borderline-like tumor of the gastrointestinal type arising from mature cystic teratoma of the ovary and its immunohistochemical cytokeratin and mucin phenotype.
Nakatsuka S; Wakimoto T; Ozaki K; Nagano T; Kimura H; Nakajo K; Ito K
J Obstet Gynaecol Res; 2012 Feb; 38(2):471-5. PubMed ID: 22230011
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types.
Rutgers JL; Bell DA
Mod Pathol; 1992 Jul; 5(4):367-71. PubMed ID: 1495942
[TBL] [Abstract][Full Text] [Related]
18. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
Aalto ML; Selkäinaho K; Collan Y
Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
